ResearcherNational Cancer Center Hospital EastActive in the last 2 years
Kanae Inoue
Matched on ORCID iD 0009-0006-4570-6383; OpenAlex author ID A5025167064. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2023: 2 papers · 2024: 2 papers · 2025: none · 2026: 1 paper
Papers 5
- Efficacy and safety of nanoliposomal irinotecan plus 5-fluorouracil and l-leucovorin in rare histological subtypes of pancreatic cancer. Co-author DOI 10.1093/jjco/hyag044↗
- Covered self-expandable metallic stent placement for tumor bleeding from duodenal invasion in patients with unresectable pancreatic cancer. Co-author DOI 10.1002/deo2.361↗
- Treatment outcomes of gemcitabine plus nab-paclitaxel in pancreatic cancer patients with malignant ascites. Co-author DOI 10.1016/j.pan.2024.03.015↗
- Palliative radiotherapy for tumor bleeding in patients with unresectable pancreatic cancer: a single-center retrospective study. Co-author DOI 10.1186/s13014-023-02367-5↗
- Correction: Palliative radiotherapy for tumor bleeding in patients with unresectable pancreatic cancer: a single-center retrospective study. Co-author DOI 10.1186/s13014-023-02377-3↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Taro Shibuki · 5 shared papers, 2023–2026 · strength 1.00
- Paper Efficacy and safety of nanoliposomal irinotecan plus 5-fluorouracil and l-leucovorin in rare histological subtypes of p… DOI 10.1093/jjco/hyag044↗
- Paper Covered self-expandable metallic stent placement for tumor bleeding from duodenal invasion in patients with unresectabl… DOI 10.1002/deo2.361↗
- Paper Treatment outcomes of gemcitabine plus nab-paclitaxel in pancreatic cancer patients with malignant ascites. DOI 10.1016/j.pan.2024.03.015↗
- Tomoyuki Satake · 5 shared papers, 2023–2026 · strength 1.00
- Paper Efficacy and safety of nanoliposomal irinotecan plus 5-fluorouracil and l-leucovorin in rare histological subtypes of p… DOI 10.1093/jjco/hyag044↗
- Paper Covered self-expandable metallic stent placement for tumor bleeding from duodenal invasion in patients with unresectabl… DOI 10.1002/deo2.361↗
- Paper Treatment outcomes of gemcitabine plus nab-paclitaxel in pancreatic cancer patients with malignant ascites. DOI 10.1016/j.pan.2024.03.015↗
- Shuichi Mitsunaga · 5 shared papers, 2023–2026 · strength 1.00
- Paper Efficacy and safety of nanoliposomal irinotecan plus 5-fluorouracil and l-leucovorin in rare histological subtypes of p… DOI 10.1093/jjco/hyag044↗
- Paper Covered self-expandable metallic stent placement for tumor bleeding from duodenal invasion in patients with unresectabl… DOI 10.1002/deo2.361↗
- Paper Treatment outcomes of gemcitabine plus nab-paclitaxel in pancreatic cancer patients with malignant ascites. DOI 10.1016/j.pan.2024.03.015↗
- Mitsuhito Sasaki · 5 shared papers, 2023–2026 · strength 1.00
- Paper Efficacy and safety of nanoliposomal irinotecan plus 5-fluorouracil and l-leucovorin in rare histological subtypes of p… DOI 10.1093/jjco/hyag044↗
- Paper Covered self-expandable metallic stent placement for tumor bleeding from duodenal invasion in patients with unresectabl… DOI 10.1002/deo2.361↗
- Paper Treatment outcomes of gemcitabine plus nab-paclitaxel in pancreatic cancer patients with malignant ascites. DOI 10.1016/j.pan.2024.03.015↗
- Masafumi Ikeda · 5 shared papers, 2023–2026 · strength 1.00
- Paper Efficacy and safety of nanoliposomal irinotecan plus 5-fluorouracil and l-leucovorin in rare histological subtypes of p… DOI 10.1093/jjco/hyag044↗
- Paper Covered self-expandable metallic stent placement for tumor bleeding from duodenal invasion in patients with unresectabl… DOI 10.1002/deo2.361↗
- Paper Treatment outcomes of gemcitabine plus nab-paclitaxel in pancreatic cancer patients with malignant ascites. DOI 10.1016/j.pan.2024.03.015↗
- Hiroshi Imaoka · 5 shared papers, 2023–2026 · strength 1.00
- Paper Efficacy and safety of nanoliposomal irinotecan plus 5-fluorouracil and l-leucovorin in rare histological subtypes of p… DOI 10.1093/jjco/hyag044↗
- Paper Covered self-expandable metallic stent placement for tumor bleeding from duodenal invasion in patients with unresectabl… DOI 10.1002/deo2.361↗
- Paper Treatment outcomes of gemcitabine plus nab-paclitaxel in pancreatic cancer patients with malignant ascites. DOI 10.1016/j.pan.2024.03.015↗
- Tomonao Taira · 5 shared papers, 2023–2026 · strength 1.00
- Paper Efficacy and safety of nanoliposomal irinotecan plus 5-fluorouracil and l-leucovorin in rare histological subtypes of p… DOI 10.1093/jjco/hyag044↗
- Paper Covered self-expandable metallic stent placement for tumor bleeding from duodenal invasion in patients with unresectabl… DOI 10.1002/deo2.361↗
- Paper Treatment outcomes of gemcitabine plus nab-paclitaxel in pancreatic cancer patients with malignant ascites. DOI 10.1016/j.pan.2024.03.015↗
- Masataka Amisaki · 1 shared paper, 2026 · strength 0.28
- Koh Fukushi · 1 shared paper, 2024 · strength 0.20
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.